Eva Chou

1.6k total citations
19 papers, 1.2k citations indexed

About

Eva Chou is a scholar working on Molecular Biology, Ophthalmology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eva Chou has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Ophthalmology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eva Chou's work include Retinal Diseases and Treatments (5 papers), Ophthalmology and Eye Disorders (5 papers) and Pituitary Gland Disorders and Treatments (4 papers). Eva Chou is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Ophthalmology and Eye Disorders (5 papers) and Pituitary Gland Disorders and Treatments (4 papers). Eva Chou collaborates with scholars based in United States and Australia. Eva Chou's co-authors include George L. King, Kerrie J. Way, Kiyoshi Suzuma, Keiko Naruse, Neil B. Ruderman, José M. Cacicedo, Yasuo Ido, Darren M. Opland, Allen C. Clermont and Izumi Suzuma and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Eva Chou

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Chou United States 10 617 268 216 198 153 19 1.2k
Kerrie J. Way Australia 14 859 1.4× 402 1.5× 475 2.2× 225 1.1× 68 0.4× 22 1.7k
Ashay D. Bhatwadekar United States 23 547 0.9× 180 0.7× 115 0.5× 140 0.7× 370 2.4× 56 1.3k
Mohammed Abdelsaid United States 23 586 0.9× 190 0.7× 85 0.4× 123 0.6× 261 1.7× 49 1.4k
Hidehiro Ishii Japan 10 588 1.0× 298 1.1× 169 0.8× 235 1.2× 454 3.0× 21 1.4k
Qing Lu United States 24 712 1.2× 132 0.5× 184 0.9× 505 2.6× 69 0.5× 47 1.9k
Amany Tawfik United States 28 753 1.2× 171 0.6× 72 0.3× 83 0.4× 497 3.2× 63 1.8k
Sylvain Galvani France 16 1.3k 2.1× 315 1.2× 136 0.6× 149 0.8× 32 0.2× 24 2.0k
Olga V. Savinova United States 17 661 1.1× 134 0.5× 130 0.6× 252 1.3× 521 3.4× 31 1.4k
Andreas Steege Germany 19 436 0.7× 337 1.3× 256 1.2× 81 0.4× 87 0.6× 38 1.0k
Hema Viswambharan United Kingdom 16 592 1.0× 631 2.4× 395 1.8× 264 1.3× 35 0.2× 39 1.6k

Countries citing papers authored by Eva Chou

Since Specialization
Citations

This map shows the geographic impact of Eva Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Chou more than expected).

Fields of papers citing papers by Eva Chou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Chou. The network helps show where Eva Chou may publish in the future.

Co-authorship network of co-authors of Eva Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Chou. A scholar is included among the top collaborators of Eva Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Chou. Eva Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hoang, Thanh D., et al.. (2024). Effects of Teprotumumab and Role of Human Leukocyte Antigens Markers in Patients With Thyroid Eye Disease. Endocrine Practice. 30(11). 1038–1043. 1 indexed citations
2.
Raiciulescu, Sorana, et al.. (2023). Innovative Curriculum to Train Medical Students on Lateral Canthotomy and Cantholysis. Military Medicine. 188(Supplement_6). 328–333.
3.
Chou, Eva, et al.. (2022). Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab. SHILAP Revista de lepidopterología. 10(11). e6621–e6621. 4 indexed citations
4.
Hoang, Thanh D., Derek J. Stocker, Eva Chou, & Henry B. Burch. (2022). 2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease. Endocrinology and Metabolism Clinics of North America. 51(2). 287–304. 56 indexed citations
5.
Hoang, Thanh D., et al.. (2021). Rapidly Progressive Cognitive Decline and Varicella Zoster Blisters Associated With Teprotumumab in 2 Patients With Graves’ Orbitopathy. Journal of the Endocrine Society. 5(Supplement_1). A950–A950.
6.
Hoang, Thanh D., et al.. (2021). Rapidly progressive cognitive decline associated with teprotumumab in thyroid eye disease. BMJ Case Reports. 14(5). e242153–e242153. 26 indexed citations
7.
Chou, Eva, et al.. (2021). Novel treatment of recurrent orbital venolymphatic malformation with sirolimus and rivaroxaban. Orbit. 41(6). 771–778. 2 indexed citations
8.
Chou, Eva, et al.. (2020). Posttraumatic Encapsulated Orbital Lipoma. Military Medicine. 185(9-10). e1876–e1879. 1 indexed citations
9.
Chou, Eva, Robert A. Mazzoli, Joseph F. Pasternak, et al.. (2018). Comparison of Simulation-Based versus Live Tissue–Based Ocular Trauma Training on Novice Ophthalmologists: Repair of Marginal Eyelid Laceration Model. SHILAP Revista de lepidopterología. 10(1). e61–e68. 2 indexed citations
10.
Chou, Eva, et al.. (2018). Rapid remodeling of the maxillary sinus in silent sinus syndrome. Orbit. 38(2). 166–168. 7 indexed citations
11.
Fernandez, Maria Paula, et al.. (2016). Histopathologic Characterization of the Expression of Vascular Endothelial Growth Factor in a Case of Retinopathy of Prematurity Treated With Ranibizumab. American Journal of Ophthalmology. 176. 134–140. 4 indexed citations
12.
Cacicedo, José M., et al.. (2011). Activation of AMP-Activated Protein Kinase Prevents Lipotoxicity in Retinal Pericytes. Investigative Ophthalmology & Visual Science. 52(6). 3630–3630. 36 indexed citations
13.
Husain, Deeba, Rosana Meyer, Manisha Mehta, et al.. (2010). Role of c-Cbl–Dependent Regulation of Phospholipase Cγ1 Activation in Experimental Choroidal Neovascularization. Investigative Ophthalmology & Visual Science. 51(12). 6803–6803. 16 indexed citations
14.
He, Zhiheng, Kerrie J. Way, Emi Arikawa, et al.. (2005). Differential Regulation of Angiotensin II-induced Expression of Connective Tissue Growth Factor by Protein Kinase C Isoforms in the Myocardium. Journal of Biological Chemistry. 280(16). 15719–15726. 56 indexed citations
15.
Cacicedo, José M., et al.. (2005). Palmitate-Induced Apoptosis in Cultured Bovine Retinal Pericytes. Diabetes. 54(6). 1838–1845. 141 indexed citations
16.
Chou, Eva, Izumi Suzuma, Kerrie J. Way, et al.. (2002). Decreased Cardiac Expression of Vascular Endothelial Growth Factor and Its Receptors in Insulin-Resistant and Diabetic States. Circulation. 105(3). 373–379. 290 indexed citations
17.
Park, Ji Young, Noriko Takahara, Annarita Gabriele, et al.. (2001). Induction Of Endothelin‐1 Expression By Glucose: An Effect Of Protein Kinase C Activation. Journal of the Peripheral Nervous System. 6(1). 60–61. 15 indexed citations
18.
Way, Kerrie J., Eva Chou, & George L. King. (2000). Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends in Pharmacological Sciences. 21(5). 181–187. 365 indexed citations
19.
Takahara, Noriko, Annarita Gabriele, Eva Chou, et al.. (2000). Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation.. Diabetes. 49(7). 1239–1248. 226 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kerrie J. Way Breakdown of academic impact, for papers by Ashay D. Bhatwadekar Breakdown of academic impact, for papers by Mohammed Abdelsaid Breakdown of academic impact, for papers by Hidehiro Ishii Breakdown of academic impact, for papers by Qing Lu Breakdown of academic impact, for papers by Amany Tawfik Breakdown of academic impact, for papers by Sylvain Galvani Breakdown of academic impact, for papers by Olga V. Savinova Breakdown of academic impact, for papers by Andreas Steege Breakdown of academic impact, for papers by Hema Viswambharan
Rankless by CCL
2026